-
1
Alpelisib-Induced Diabetic Ketoacidosis and Insulin-Resistant Hyperglycemia
Published 2025-01-01Subjects: Get full text
Article -
2
Expert insights on Hodgkin’s lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment
Published 2025-01-01Subjects: Get full text
Article -
3
CD36 inhibition enhances the anti-proliferative effects of PI3K inhibitors in PTEN-loss anti-HER2 resistant breast cancer cells
Published 2025-02-01Subjects: Get full text
Article